RadNet, Inc.

NasdaqGM RDNT

RadNet, Inc. Price to Book Ratio (P/B) on January 14, 2025: 5.93

RadNet, Inc. Price to Book Ratio (P/B) is 5.93 on January 14, 2025, a 28.34% change year over year. Price to book ratio compares the stock price to the book value per share; above 1 indicates market values company more than its book value.
  • RadNet, Inc. 52-week high Price to Book Ratio (P/B) is 7.80 on November 11, 2024, which is 31.58% above the current Price to Book Ratio (P/B).
  • RadNet, Inc. 52-week low Price to Book Ratio (P/B) is 4.50 on February 07, 2024, which is -24.08% below the current Price to Book Ratio (P/B).
  • RadNet, Inc. average Price to Book Ratio (P/B) for the last 52 weeks is 5.91.
Key data
Date Price to Book Ratio (P/B) Dividend Yield Free Cash Flow Yield Price to Earnings Ratio (P/E)
Market news
Loading...
NasdaqGM: RDNT

RadNet, Inc.

CEO Dr. Howard G. Berger M.D.
IPO Date Jan. 3, 1997
Location United States
Headquarters 1508, 1510 and 1516 Cotner Avenue
Employees 10,000
Sector Health Care
Industries
Description

RadNet, Inc., together with its subsidiaries, provides outpatient diagnostic imaging services in the United States. Its services include magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and other related procedures, as well as multi-modality imaging services. The company also develops and sells computerized systems for the diagnostic imaging industry, including picture archiving communications systems and related services; and develops and deploys AI suites to enhance radiologist interpretation of images in the field of mammography, as well as AI solutions for lung and prostate cancer. As of December 31, 2021, it owned and managed 347 centers in Arizona, California, Delaware, Florida, Maryland, New Jersey, and New York. The company was founded in 1981 and is headquartered in Los Angeles, California.

Similar companies

QGEN

Qiagen N.V.

USD 45.57

-0.94%

BDSX

Biodesix, Inc.

USD 1.15

-7.26%

XGN

Exagen Inc.

USD 3.00

-3.85%

BNR

Burning Rock Biotech Limited

USD 6.55

-6.69%

SERA

Sera Prognostics, Inc.

USD 6.37

0.63%

FONR

FONAR Corporation

USD 15.16

0.20%

MYGN

Myriad Genetics, Inc.

USD 13.68

-4.20%

SHC

Sotera Health Company

USD 12.76

-2.52%

ACRS

Aclaris Therapeutics, Inc.

USD 2.50

0.81%

NEOG

Neogen Corporation

USD 12.00

-5.06%

StockViz Staff

January 15, 2025

Any question? Send us an email